We link leading research sites to create networks of excellence in 40 countries

Our networks combine experienced academic and community sites for early and late-phase trials, supported by our skilled medical and operational teams in all major therapeutic areas.


     

Leading sites in global networks of excellence

Link leading academic institutions, community sites, patients and care-givers, providers and payers in thousands of locations in more than 40 countries across US and Canada, Latin America, Europe, Africa, the Middle East, Australia and New Zealand, and Asia for investigation of new diagnostics, drugs and devices, and evaluation of clinical, economic and humanistic benefit.


From common disorders to rare diseases

Syreon excels not only in common therapeutic areas, but also in the advancing technologies of molecular sciences, stem cell transplantation and therapeutics, immune disease and immuno-oncology, and in the broader areas of organ failure, inflammatory disease and targeted therapy. We complement our trials with companion studies to evaluate costs and develop pricing strategies, to support market access, and to monitor effective clinical use and economic value in today's competitive health environment.


Specialized resources for every need

Syreon provides the specialized research resources required for each particular research program from early phase PK / PD Phase 1/2a studies to at-home telemonitoring of cardiopulmonary function and other physiological parameters. We work with leading fully-accredited laboratories for specialized testing and communicate patient preferences and responses via rapid and simple ePRO applications.


High-performing sites

Select the most committed and capable investigators from our global registry to achieve enrolment and performance goals. Draw on the expertise and experience of these global top performers to adjust design or scale as trial data dictates.


Study modeling

Avoid expensive errors and delays by combining advanced trial methods of adaptive study design, clustered population-based trials or propensity score allocation with prospective study modeling, integrating studies in a tight, logical sequence with early analysis for corporate decisions.


IWRS and ECTM

ClinStream technology integrates a sophisticated Interactive Web-based Response System (IWRS) for online subject randomization and treatment allocation, with Electronic Clinical Trial Management (ECTM) to train and support research teams and speed IRB approval.


High study profile

Ensure the study visibility and profile you need to engage participants through a professional suite of coordinated study-branded promotional posters, information brochures, press announcements, advertisements, internet and broadcast advertising, and other customized approaches.


Enhanced compliance

Maximize retention and compliance via rigorous site-management that fosters active personal engagement, identifies potential barriers and solutions, provides reminders and appreciation for completion of key stages, and ensures continuous communication to reduce drop-out.


Clinical team support

Minimize trial demands by providing support at all stages from participant screening and selection, to clinic booking and organization of research visits, or calls to provide participant support and ensure completion of critical tests and outcome reports.